This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Resumen de acción APEN
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy.
| Puntuación del snowflake | |
|---|---|
| Valoración | 0/6 |
| Crecimiento futuro | 2/6 |
| Rendimiento pasado | 0/6 |
| Salud financiera | 5/6 |
| Dividendos | 0/6 |
Competidores de Apollo Endosurgery, Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$10.00 |
| Máximo en las últimas 52 semanas | US$10.30 |
| Mínimo de 52 semanas | US$3.49 |
| Beta | 2.32 |
| 1Cambio en 1 mes | 0.50% |
| Variación en 3 meses | 1.11% |
| Cambio de 1 año | 67.79% |
| 3Variación en 3 años | 360.83% |
| Variación en 5 años | 70.94% |
| Variación desde la OPV | -17.76% |
Noticias y actualizaciones recientes
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Recent updates
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Apr 03Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?
Nov 30Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?
Aug 05Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings
Aug 04Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?
Mar 02Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?
Aug 04Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy
Jun 28Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?
May 05Apollo Endosurgery EPS beats by $0.05, beats on revenue
May 04A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)
Mar 24What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?
Mar 03Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares
Feb 10We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt
Jan 31Assessing Apollo Endosurgery
Dec 27If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%
Dec 27Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?
Dec 01Apollo Endosurgery EPS beats by $0.10, beats on revenue
Nov 05Rentabilidad de los accionistas
| APEN | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 0.8% | 1.0% | 1.1% |
| 1Y | 67.8% | 26.6% | 32.2% |
Rentabilidad vs. Industria: APEN exceeded the US Medical Equipment industry which returned -13.3% over the past year.
Rentabilidad vs. Mercado: APEN exceeded the US Market which returned -11.4% over the past year.
Volatilidad de los precios
| APEN volatility | |
|---|---|
| APEN Average Weekly Movement | 0.5% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 14.7% |
| 10% least volatile stocks in US Market | 3.1% |
Precio estable de las acciones: APEN has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: APEN's weekly volatility has decreased from 12% to 1% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2005 | 202 | Chas McKhann | www.apolloendo.com |
Resumen de fundamentos de Apollo Endosurgery, Inc.
| Estadísticas fundamentales de APEN | |
|---|---|
| Capitalización bursátil | US$579.72m |
| Beneficios(TTM) | -US$39.84m |
| Ingresos (TTM) | US$76.86m |
7.5x
Ratio precio-ventas (PS)-14.6x
Ratio precio-beneficio (PE)¿Está APEN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de APEN | |
|---|---|
| Ingresos | US$76.86m |
| Coste de los ingresos | US$34.43m |
| Beneficio bruto | US$42.43m |
| Otros gastos | US$82.27m |
| Beneficios | -US$39.84m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.69 |
| Margen bruto | 55.20% |
| Margen de beneficio neto | -51.84% |
| Ratio deuda/patrimonio | 164.7% |
¿Cómo se ha desempeñado APEN a largo plazo?
Ver rendimiento histórico y comparativa